United States Overactive Bladder Treatment Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Overactive Bladder Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Overactive Bladder Treatment Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Overactive Bladder Treatment Overall Market Size
2.1 United States Overactive Bladder Treatment Market Size: 2021 VS 2027
2.2 United States Overactive Bladder Treatment Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Overactive Bladder Treatment Players in United States Market
3.2 Top United States Overactive Bladder Treatment Companies Ranked by Revenue
3.3 United States Overactive Bladder Treatment Revenue by Companies
3.4 Top 3 and Top 5 Overactive Bladder Treatment Companies in United States Market, by Revenue in 2020
3.5 Companies Overactive Bladder Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Overactive Bladder Treatment Players in United States Market
3.6.1 List of Tier 1 Overactive Bladder Treatment Companies in United States
3.6.2 List of Tier 2 and Tier 3 Overactive Bladder Treatment Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Overactive Bladder Treatment Market Size Markets, 2021 & 2027
4.1.2 Drugs
4.1.3 Device
4.2 By Type - United States Overactive Bladder Treatment Revenue & Forecasts
4.2.1 By Type - United States Overactive Bladder Treatment Revenue, 2016-2021
4.2.2 By Type - United States Overactive Bladder Treatment Revenue, 2022-2027
4.2.3 By Type - United States Overactive Bladder Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Overactive Bladder Treatment Market Size, 2021 & 2027
5.1.2 Idiopathic Overactive Bladder
5.1.3 Neurogenic Overactive Bladder
5.2 By Application - United States Overactive Bladder Treatment Revenue & Forecasts
5.2.1 By Application - United States Overactive Bladder Treatment Revenue, 2016-2021
5.2.2 By Application - United States Overactive Bladder Treatment Revenue, 2022-2027
5.2.3 By Application - United States Overactive Bladder Treatment Revenue Market Share, 2016-2027
6 Overactive Bladder Treatment Companies Profiles
6.1 Allergan
6.1.1 Allergan Company Details
6.1.2 Allergan Business Overview
6.1.3 Allergan Overactive Bladder Treatment Introduction
6.1.4 Allergan Overactive Bladder Treatment Revenue in United States Market (2016-2021)
6.1.5 Allergan Recent Developments
6.2 Astellas Pharma
6.2.1 Astellas Pharma Company Details
6.2.2 Astellas Pharma Business Overview
6.2.3 Astellas Pharma Overactive Bladder Treatment Introduction
6.2.4 Astellas Pharma Overactive Bladder Treatment Revenue in United States Market (2016-2021)
6.2.5 Astellas Pharma Recent Developments
6.3 Pfizer
6.3.1 Pfizer Company Details
6.3.2 Pfizer Business Overview
6.3.3 Pfizer Overactive Bladder Treatment Introduction
6.3.4 Pfizer Overactive Bladder Treatment Revenue in United States Market (2016-2021)
6.3.5 Pfizer Recent Developments
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Details
6.4.2 Johnson & Johnson Business Overview
6.4.3 Johnson & Johnson Overactive Bladder Treatment Introduction
6.4.4 Johnson & Johnson Overactive Bladder Treatment Revenue in United States Market (2016-2021)
6.4.5 Johnson & Johnson Recent Developments
6.5 Medtronic
6.5.1 Medtronic Company Details
6.5.2 Medtronic Business Overview
6.5.3 Medtronic Overactive Bladder Treatment Introduction
6.5.4 Medtronic Overactive Bladder Treatment Revenue in United States Market (2016-2021)
6.5.5 Medtronic Recent Developments
6.6 KYORIN Pharmaceutical
6.6.1 KYORIN Pharmaceutical Company Details
6.6.2 KYORIN Pharmaceutical Business Overview
6.6.3 KYORIN Pharmaceutical Overactive Bladder Treatment Introduction
6.6.4 KYORIN Pharmaceutical Overactive Bladder Treatment Revenue in United States Market (2016-2021)
6.6.5 KYORIN Pharmaceutical Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Overactive Bladder Treatment Market Opportunities & Trends in United States Market
Table 2. Overactive Bladder Treatment Market Drivers in United States Market
Table 3. Overactive Bladder Treatment Market Restraints in United States Market
Table 4. Key Players of Overactive Bladder Treatment in United States Market
Table 5. Top Overactive Bladder Treatment Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Overactive Bladder Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Overactive Bladder Treatment Revenue Share by Companies, 2016-2021
Table 8. Companies Overactive Bladder Treatment Product Type
Table 9. List of Tier 1 Overactive Bladder Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Overactive Bladder Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Overactive Bladder Treatment Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Overactive Bladder Treatment Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Overactive Bladder Treatment Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Overactive Bladder Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Overactive Bladder Treatment Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Overactive Bladder Treatment Revenue (US$, Mn), 2022-2027
Table 17. Allergan Company Details
Table 18. Allergan Business Overview
Table 19. Allergan Overactive Bladder Treatment Product
Table 20. Allergan Overactive Bladder Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Allergan Recent Developments
Table 22. Astellas Pharma Company Details
Table 23. Astellas Pharma Business Overview
Table 24. Astellas Pharma Overactive Bladder Treatment Product
Table 25. Astellas Pharma Overactive Bladder Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Astellas Pharma Recent Developments
Table 27. Pfizer Company Details
Table 28. Pfizer Business Overview
Table 29. Pfizer Overactive Bladder Treatment Product
Table 30. Pfizer Overactive Bladder Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Pfizer Recent Developments
Table 32. Johnson & Johnson Company Details
Table 33. Johnson & Johnson Business Overview
Table 34. Johnson & Johnson Overactive Bladder Treatment Product
Table 35. Johnson & Johnson Overactive Bladder Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Johnson & Johnson Recent Developments
Table 37. Medtronic Company Details
Table 38. Medtronic Business Overview
Table 39. Medtronic Overactive Bladder Treatment Product
Table 40. Medtronic Overactive Bladder Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Medtronic Recent Developments
Table 42. KYORIN Pharmaceutical Company Details
Table 43. KYORIN Pharmaceutical Business Overview
Table 44. KYORIN Pharmaceutical Overactive Bladder Treatment Product
Table 45. KYORIN Pharmaceutical Overactive Bladder Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. KYORIN Pharmaceutical Recent Developments
List of FiguresFigure 1. Overactive Bladder Treatment Segment by Type
Figure 2. Overactive Bladder Treatment Segment by Application
Figure 3. United States Overactive Bladder Treatment Market Overview: 2020
Figure 4. United States Overactive Bladder Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Overactive Bladder Treatment Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Overactive Bladder Treatment Revenue in 2020
Figure 7. By Type - United States Overactive Bladder Treatment Revenue Market Share, 2016-2027
Figure 8. By Application - United States Overactive Bladder Treatment Revenue Market Share, 2016-2027
Figure 9. Allergan Overactive Bladder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Astellas Pharma Overactive Bladder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Pfizer Overactive Bladder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Johnson & Johnson Overactive Bladder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Medtronic Overactive Bladder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. KYORIN Pharmaceutical Overactive Bladder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)